Immunotherapy advancements: transforming cancer treatment
In recent years, immunotherapy has emerged as a revolutionary approach in cancer treatment, harnessing the power of the immune system to combat cancer cells. This webinar will explore the latest advancements in immunotherapy research, highlighting breakthroughs, challenges, and future directions in the field. Participants will gain insights, including immune checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines.
Refining and targeting exatecan with ADC technology
By Drug Target Review
Empowering women in STEM: Navigating CMC regulatory affairs
By Drug Target Review
Hope for ALS and inflammatory diseases: Cellenkos’ CRANE technology breakthrough
By Drug Target Review
The future of cell therapy: scaling production for global reach
By Drug Target Review
Bacterial ‘jumping genes’ found to control chromosome ends
Cornell researchers have discovered how transposons, or ‘jumping genes,’ insert themselves into bacterial chromosome ends, potentially transforming genetic engineering and advancing biotechnology. This breakthrough could reshape antibiotic research and unlock new drug discoveries.
New AI algorithm searches 10 sextillion drug candidates
Scientists have developed an AI algorithm capable of searching through 10 sextillion potential drug molecules, a feat previously considered impossible. This method could significantly speed up drug discovery and the development of new treatments.
Leukaemia cells hit hard by innovative dual-drug approach
Scientists have discovered a dual-drug therapy that dramatically increases leukaemia cell death, offering new hope for patients with acute myeloid leukaemia (AML). By combining SRC and MCL-1 inhibitors, this approach opens the door to more effective treatments.
Shattering the glass ceiling: empowering women and girls in STEM
By Dr Vasiliki E Kalodimou - Assistant Professor of Biology…